Jump to content

Precision BioSciences, Inc. (20250152679). DYSTROPHIN GENE EXON DELETION USING ENGINEERED NUCLEASES

From WikiPatents

DYSTROPHIN GENE EXON DELETION USING ENGINEERED NUCLEASES

Abstract: the invention relates to the field of molecular biology and recombinant nucleic acid technology. in particular, the invention relates to a method of treating a patient with duchenne muscular dystrophy comprising the removal of at least one exon from the dystrophin gene using engineered nucleases.

IPC:

CPC: A61K38/465,

Retrieved from "https://wikipatents.org/index.php?title=Precision_BioSciences,_Inc._(20250152679)._DYSTROPHIN_GENE_EXON_DELETION_USING_ENGINEERED_NUCLEASES&oldid=568804"

Cookies help us deliver our services. By using our services, you agree to our use of cookies.